An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals https://www.reuters.com/markets/companies/ABOS.O” target=”_blank” rel=”noopener”>(ABOS.O) targeting a novel form of the toxic protein beta amyloid in the brain passed an early safety t…
Read More
About The Author
